Acrylates and Methacrylates Sensitization in Patients with Orthopedic and Dental Prostheses: Asymptomatic Pre-Implant and Symptomatic Post-Implant Testing
View abstract on PubMed
Summary
This summary is machine-generated.This study found that 4.2% of patients showed acrylate sensitization, with previous dermatitis and respiratory allergies increasing risk. Acrylate sensitization prevalence was similar in patients before and after prosthesis application.
Area Of Science
- Dermatology
- Allergy Immunology
- Materials Science
Background
- Acrylates and methacrylates are common sensitizers used in medical devices and consumer products.
- Potential for allergic contact dermatitis necessitates understanding sensitization prevalence.
Purpose Of The Study
- To determine the prevalence of acrylate sensitization in patients undergoing dental or orthopedic procedures.
- To investigate factors associated with acrylate sensitization.
- To compare sensitization rates before and after prosthesis implantation.
Main Methods
- Patch testing was performed on 882 patients using a panel of common acrylates and methacrylates.
- Multivariable logistic regression analyzed factors linked to sensitization.
- Patients were categorized into pre-implant and post-implant groups.
Main Results
- Overall, 4.2% of patients exhibited patch test positivity to at least one acrylate.
- Previous dermatitis (OR 2.38) and respiratory allergy (OR 2.96) were significant risk factors for sensitization in the pre-implant group.
- Prevalence of sensitization to specific acrylates included EGDMA (3.5%), EA (2.7%), and 2-HEMA (1.5%).
- No significant difference in sensitization prevalence was observed between pre-implant and post-implant groups.
Conclusions
- Acrylate sensitization prevalence is similar in patients before and after prosthesis placement.
- Further research is needed on patch test accuracy and clinical relevance of acrylate sensitization.
- Detailed exposure history is crucial for evaluating potential acrylate-related contact dermatitis.

